… a confirmed COVID-19. Due to there is disagreement in MSCs therapy to treat COVID-19, …
information to researchers and enthusiasts of the stem cell-based therapy field. In this study, …

… stem cell therapy in COVID-19, and registered COVID-19 clinical trials. Of all the stem
cell therapies touted for COVID-19 treatment, mesenchymal stem cells (MSCs) or MSC-like …

… Most countries are likely to have spread of COVID-19, at least in the early stages, … COVID-19
using stem cells, and how benefit might be scaled and simplified using synthetic stem cells …

… The first reports of the use of allogeneic umbilical cord stem cells in a patient with COVID-19 …
The therapy was carried out on a 65-year-old patient with respiratory failure and COVID-19 …

… , these cells secrete bioactive factors that are immunomodulatory and trophic, meaning
that these cells … Below we describe the mechanisms of action of mesenchymal stem cells (MSCs). …

… stem cells are known to exert immunomodulatory and anti-inflammatory effects and could
yield beneficial effects in COVID-19 … stem cell (UC-MSC) infusions in subjects with COVID-19 …

… in severe or critical COVID-19 than those in SARS. Mesenchymal stem cells (MSCs), which
… As one of the most widely studied adult stem cells in regenerative medicine, MSCs produce …

… of coronavirus disease 2019 (COVID-19). There are a few reports of allogeneic human
mesenchymal stem cells (… and umbilical cord, in critically ill COVID-19-induced ARDS patients. …

… mesenchymal stem cells (MSCs) into seven patients with Coronavirus Disease 2019 (COVID-19)
resulted in improved functional outcomes and facilitated recovery [1]. COVID-19 is a …

… of MSCs in improving COVID-19 patient outcomes via … cells of COVID-19 patients, we
compared the expression levels of integrin signaling molecules in PBMCs isolated from COVID-19 …